Description du poste
This is an edited transcript of a talk I gave at EAG
NYC 2026.
I'm Jeff Kaufman, and I lead
SecureBio Detection.
There's a lot of interest right now in new projects to reduce
catastrophic risk, and I thought it would be interesting to look at
how the project of SecureBio Detection grew from a concept to a
running system.
I should warn you up front, I am a very narrative-driven person, and
so a lot of this will feel a bit neat, as if stages inexorably flowed
together. But the real world is messy and contingent, with key
decisions downstream from mistakes, personality conflicts, and
luck. There are generalizable insights here, however, and I'm going to
see what I can share.
I joined the project early on, but wasn't there for the beginning: I
can't speak to quite the whole journey. Instead, I'll start by
introducing you to these ideas as I first encountered them.
I learned about the idea of building a pandemic early warning system
on the EA
Forum. Andrew Snyder-Beattie, who led (and still leads)
Coefficient Giving's biosecurity
grant-making program, and Ethan Alley, who at the time was running
the vaccine startup Alvea,
shared a list
of concrete projects to reduce catastrophic biorisk. First on the
list was an early detection center. I remember reading about it, and
that seemed like an interesting idea. I thought, it would be really
good for some people to go work on that. And then I kept scrolling.
At the time, I was earning to give at a
job I liked. I was pretty content. But then, a few months later, I
was talking to some EA friends about whether I could be doing
something more valuable, and I realized, actually, biosecurity was a
place I could contribute. And as I talked to more people and started
to look for biosecurity projects to work on, one that seemed
particularly promising was the Nucleic
Acid Observatory. Will Bradshaw, Mike McLaren, and Anjali Gopal
had founded it within Kevin Esvelt's lab at
MIT, and I talked with them, quickly became very excited, a